Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study

Four formulations of an investigational tetravalent dengue purified inactivated vaccine, administered as two doses one month (M) apart, were previously shown to be immunogenic and well-tolerated up to M13 of the phase I study NCT01702857. Here, we report results of the follow-up from M14 to year (Y)...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Trop Med Hyg
Hlavní autoři: Diaz, Clemente, Koren, Michael, Lin, Leyi, Martinez, Luis J., Eckels, Kenneth H., Campos, Maribel, Jarman, Richard G., De La Barrera, Rafael, Lepine, Edith, Febo, Irma, Vaughn, David W., Wilson, Todd M., Paris, Robert M., Schmidt, Alexander C., Thomas, Stephen J.
Médium: Artigo
Jazyk:Inglês
Vydáno: The American Society of Tropical Medicine and Hygiene 2020
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7204593/
https://ncbi.nlm.nih.gov/pubmed/32124728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.19-0461
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky